“…The GPA assay was proposed to provide an evaluation of the life-span cumulative exposure for humans, because it detects mutations preserved at the level of red blood stem cells during the lifetime of an individual. GPA variants were found to be at significantly increased frequency among Hiroshima A-bomb survivors; the assay was tentatively used as a biodosimeter of cumulative exposure after the fall-out in the Chernobyl nuclear power center [2,5,9,16,18,26]. The GPA assay by FCM was also used for monitoring the genotoxic load in cancer patients who underwent radio-or chemotherapy [4,12,15,22,24,27], in workers exposed to styrene [6,10] and, in association with DNA adducts, for foundry workers exposed to polycyclic aromatic hydrocarbons [25].…”